The location of positive nodes partly influences the prognostic value of the number of positive nodes in breast cancer patients

Japanese Journal of Clinical Oncology

Volumn 29, Issue 2, 1999, Pages 63-67

  Utada, Yoshihito ^a,b   Kasumi, Fujio ^a   Yoshimoto, Masataka ^a   Tada, Takashi ^a   Saitoh, Mitsue ^a   Takahashi, Kaoru ^a   Akiyama, Futosi ^a   Sakamoto, Goi ^a   Nishi, Mitsumasa ^a  

^a CANCER INSTITUTE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Breast cancer; Location number; Lymph node metastasis; Number of positive nodes; Survival rate

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CELL COUNT; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL COUNT; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 0033071816     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.2.63     Document Type: Article

References (14)

1. Izuo M. Nyuusen Sikkan. Tokyo 1993;332-41 (in Japanese).
2. General Rules for Clinical and Pathological Recording of Breast Cancer, 12th ed. Tokyo: Japanese Breast Cancer Society 1996.
3. Adair F, Berg J, Joubert L, Robbins G F. Long-term follow-up of breast cancer patients, the 30-year report. Cancer 1974;33:1145-50.
4. Fisher B, Ravdin RG, Ausman RK, Slack NH, Moore GE, Noer RJ. Surgical adjuvant chemotherapy in cancer of the breast. Ann Surg 1968;168:337-56.
5. Miura S.The prognostic significance of axillary node metastasis in breast cancer. Nyuugan No Rinsyou 1995;10:452-9 (in Japanese).
6. Hiratsuka M, Miura S, Murai H, Takeuti T, Mokuzen H, Itinose M, et al. The prognostic significance of node metastasis in breast cancer.Nyuugan No Rinsyou 1994;9:242-5 (in Japanese).
7. Fisher B, Bauer M, Wickeehan W, Redmond CK, Fisher E. Relationship of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983;52:1551-7.
8. Nogutchi M, Miwa K, Michigushi T, Yokoyama K, Nishijima H, Takanaka T, et al. The role of axillary lymph node dissection in breast cancer management. Breast Cancer 1997;4:143-53.
9. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674-81.
10. Amando EG, Daniel MK, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
11. Senofsky GM, Moffat FL, Davis K, Marsi MM, Clark KC, Robinson DS, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991;126:1336-42.
12. Elizabeth CD, Lawrence NS, Wiley WS, Smith BL. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer. Ann Surg 1997;226:279-87.
13. Veronesi U, Rilke F, Luini A, Sacchini V, Garimberti V, Campa T, et al. Distribution of axillary node metastasis by level of invasion. Cancer 1987;59:682-7.
14. Auchincloss H. Significance of location and number of axillary metastases in carcinoma of the breast. Ann Surg 1963;158:37-46.